The Comparison of Pulse Oximetry, End-tidal Capnometry, and Integrated Pulmonary Index (IPI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01191528|
Recruitment Status : Completed
First Posted : August 31, 2010
Last Update Posted : December 13, 2010
|Condition or disease||Intervention/treatment|
|Postoperative Care||Device: capnostream 20, Oridian Medical 1987 ltd, Needham MA|
A simple comparison design will be used to compare pulse SpO2 monitoring of respiratory status to a combination of pulse SpO2 monitoring and EtCO2 nasal cannula monitoring with Integrated Pulmonary Index (IPI). Using combination monitor, each subject will serve as their own control with repeated measurements of respiratory rate, SpO2, EtCO2 and IPI at 5 second intervals. Patients will be monitored for a minimum of 8 hours after admission to the acute care unit and through the first night.
Subjects for this study will be a convenience sample post-operative in-patients admitted to 2 East after surgery at Allenmore Hospital/Multicare Health System a 75 bed community facility.
|Study Type :||Observational|
|Actual Enrollment :||60 participants|
|Official Title:||The Comparison of Pulse Oximetry, End-tidal Capnometry, and Integrated Pulmonary Index in Adult Post-operative Patients|
|Study Start Date :||August 2010|
|Actual Primary Completion Date :||December 2010|
|Actual Study Completion Date :||December 2010|
- Device: capnostream 20, Oridian Medical 1987 ltd, Needham MA
Oxygen blood saturation measured by a s sensor that reflects infrared light on oxygenated and deoxygenated arterial blood via a noninvasive, clip on digit sensor connected to a combination capnometer and pulse oximeter monitor.
End-tidal Carbon dioxide (EtCO2) is measured with a noninvasive nasal cannula sampling line which calculates the EtCO2 from exhaled air. Measurements recorded at 5 second intervals.Other Name: OxiMax Nellcor, Covidien, Capnoline, Oridion Medical
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01191528
|United States, Washington|
|Tacoma, Washington, United States, 98411|
|Principal Investigator:||Julie M Northrup, ADN, BC||Multicare Health System-Allenmore Hospital|
|Principal Investigator:||Jennifer Spotted-Horse, MS,BSN,OCN||Multicare Health System-Allenmore Hospital|
|Principal Investigator:||Dawn Fox, RN||Multicare Health System-Allenmore Hosptial|
|Principal Investigator:||David Lechich, RN||Multicare Health System-Allenmore Hospital|
|Principal Investigator:||Joan Fortune, RN||Multicare Health System Allenmore Hospital|
|Principal Investigator:||Katy Rogers, RN||Multicare Health System, Allenmore Hospital|
|Principal Investigator:||Lynn Arnold, RN||Multicare Health System Allenmore Hospital|
|Principal Investigator:||Lisa Ettlin-Porter, BSN,RN,CCRN||Multicare Health System Allenmore Hospital|
|Principal Investigator:||Dee Harris, BS,RRT,RPFT||Multicare Health System Allenmore Hospital|
|Principal Investigator:||Colleen Doherty, PhD(c),RN||Consultant-Multicare Health System Allenmore Hospital|